Skip to main content
logo
BioInvent International AB (publ) (STO:BINV)
Sweden flag Sweden · Delayed Price · Currency is SEK
23.20
+0.25 (1.09%)
Apr 14, 2026, 5:29 PM CET

STO:BINV Revenue

In the year 2025, BioInvent International AB had annual revenue of 226.50M SEK with 406.86% growth. BioInvent International AB had revenue of 3.02M in the quarter ending December 31, 2025, a decrease of -85.89%.

Revenue
226.50M
Revenue Growth
+406.86%
P/S Ratio
6.67
Revenue / Employee
2.08M
Employees
124
Market Cap
1.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025226.50M181.81M406.86%
Dec 31, 202444.69M-26.78M-37.47%
Dec 31, 202371.46M-254.67M-78.09%
Dec 31, 2022326.13M306.74M1,582.45%
Dec 31, 202119.38M-127.99M-86.85%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Saniona AB434.40M
Cantargia AB316.70M
Hansa Biopharma AB222.27M
Genovis AB (publ.)129.65M
Egetis Therapeutics AB62.40M
Medivir AB8.51M
Vicore Pharma Holding AB3.82M
Flerie AB2.50M
Revenue Rankings

BioInvent International AB News

More News